Elanco Animal Health Incorporated Common Stock

Day range

$22.18 – $22.90

Open

$22.62

Prev close

$22.52

Volume

2.34M

Market cap

$11.25B

Shares out

499.62M

P/E

—

P/S

2.24

P/B

1.71

P/FCF

29.69

ROE

-3.0%

ROA

-1.5%

Debt/Equity

0.59

Div yield

0.00%

As of Oct 23, 2026

• Guidance issuance or updateAug 5, 2026

  Attached as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated August 5, 2026, announcing the results of operations for the fiscal quarter ended June 30, 2026, and guidance for the full year and third quarter of 2026, for Elanco Animal Health Incorporated.

• Guidance issuance or updateMay 6, 2026

  Attached as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated May 6, 2026, announcing the results of operations for the fiscal quarter ended March 31, 2026, and guidance for the full year and second quarter of 2026, for Elanco Animal Health Incorporated.

• Guidance issuance or updateFeb 24, 2026

  Attached as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated February 24, 2026, announcing the results of operations for the full year and fiscal quarter ended December 31, 2025, and guidance for the full year and first quarter of 2026

• Investor presentationJan 12, 2026

  On January 13, 2026, Elanco Animal Health Incorporated (the "Company") will present at the 44th Annual J.P. Morgan Healthcare Conference (the "JPM Conference"). A copy of the Company's JPM Conference presentation is furnished as Exhibit 99.1.

• Restructuring planDec 9, 2025

  On December 5, 2025, the Board of Directors of Elanco Animal Health Incorporated (the "Company") authorized a restructuring plan with respect to its workforce (the "Restructuring Plan") to support margin expansion, optimize the Company's footprint, and further invest in innovation. The Restructuring Plan will result in a global headcount reduction of approximately 300 employees, plus an approximate 300 employees whose positions will be replaced with positions in growth areas or in lower-cost geographies. Expected pretax charges associated with the Restructuring Plan total approximately $175 million.

Days to cover

6.2

Short interest

37.29M

Avg volume

6.05M

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?
  positiveZacks Investment Research· Oct 19, 2026
• Elanco Director Purchases 40,000 Shares for $936,000
  positiveThe Motley Fool· Sep 4, 2026
• Veterinary API Manufacturing Market to Reach USD 18.48 Billion by 2035 as Animal Health Investments and Zoonotic Disease Prevention Accelerate – SNS Insider
  positiveGlobeNewswire Inc.· Jun 18, 2026
• Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum
  positiveBenzinga· May 6, 2026
• PRISM MarketView Launches PetCare Index
  positiveGlobeNewswire Inc.· Feb 12, 2026